With this extension, IXCHIQ ® , the first vaccine against the chikungunya virus (CHIKV), is now available for administration for individuals 12 ...

[Presse Océan] Premier vaccin autorisé au monde contre le virus du chikungunya, le Ixchiq, mis au point par le labo nantais, ...

Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) (“Valneva” or the “Company”), a specialty vaccine company, today announces that it has filed a prospectus supplement as part of the renewal of its ...

Valneva also has an ongoing license agreement with the Serum Institute of India (SII) to supply its vaccine at an affordable ...

Valneva responds to French govt’s call for supply of chikungunya vaccine, Ixchiq: Saint Herblain, France Wednesday, March 26, 2025, 17:00 Hrs [IST] Valneva SE, a specialty vacci ...

VALNEVA Saint Herblain (France), March 24, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that it is responding to the chikungunya outbreak ...

Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that it has submitted a label extension application to the Medicines and Healthcare products Regulatory ...

Saint Herblain , le 31 mars 2025 – Valneva SE , société spécialisée dans les vaccins, a annoncé aujourd’hui avoir soumis une demande d’élargissement de l’indication de son vaccin ...

Yes, Valneva had another successful year in 2024 ... 2024 in the United States and at the end of the year in Canada and France and we recognized initial sales for the financial year 2024 of ...

Saint Herblain (France), March 31, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that it has submitted a label extension application to the ...